EMA GL: Batch size in validation [Bioanalytics]

posted by Helmut Homepage – Vienna, Austria, 2010-06-10 16:43 (5862 d 12:44 ago) – Posting: # 5492
Views: 7,909

Dear all,

the draft guideline states in Section 4.1.5 Accuracy, lines 196-198:

To enable evaluation of any trends over time within one run, it is recommended to demonstrate accuracy of QC samples over at least one of the runs with a size equivalent to a prospective analytical run.

According to the EUFEPS/EBF-workshop last April I would expect that this statement will 'make it' to the final version.

We have one validated method (GC/MS stable isotope IS) which is in routine use for numerous years. Until now we have analyzed ~8300 samples and had not a single batch rejected (86 batches, size 72-108 study samples/batch, average 96 samples without calibrators/QCs). What do you think? Will regulators insist in performing a new validation run in ~110 samples or would it be sufficient to refer to historical data?

Dif-tor heh smusma 🖖🏼 Довге життя Україна! [image]
Helmut Schütz
[image]

The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes

Complete thread:

UA Flag
Activity
 Admin contact
23,655 posts in 4,993 threads, 1,570 registered users;
338 visitors (0 registered, 338 guests [including 15 identified bots]).
Forum time: 05:27 CEST (Europe/Vienna)

Most scientists today are devoid of ideas, full of fear, intent on
producing some paltry result so that they can add to the flood
of inane papers that now constitutes “scientific progress”
in many areas.    Paul Feyerabend

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5